PT1227797E - Formulacoes farmaceuticas de dispersao solida - Google Patents

Formulacoes farmaceuticas de dispersao solida

Info

Publication number
PT1227797E
PT1227797E PT00977140T PT00977140T PT1227797E PT 1227797 E PT1227797 E PT 1227797E PT 00977140 T PT00977140 T PT 00977140T PT 00977140 T PT00977140 T PT 00977140T PT 1227797 E PT1227797 E PT 1227797E
Authority
PT
Portugal
Prior art keywords
solid dispersion
pharmaceutical formulations
disclosed
methods
soliddispersion
Prior art date
Application number
PT00977140T
Other languages
English (en)
Inventor
Yihong Qiu
Steven L Krill
James J Fort
Law Devalina
William R Porter
Eric A Schmitt
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23745019&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1227797(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PT1227797E publication Critical patent/PT1227797E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT00977140T 1999-11-12 2000-11-10 Formulacoes farmaceuticas de dispersao solida PT1227797E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43951499A 1999-11-12 1999-11-12

Publications (1)

Publication Number Publication Date
PT1227797E true PT1227797E (pt) 2005-05-31

Family

ID=23745019

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00977140T PT1227797E (pt) 1999-11-12 2000-11-10 Formulacoes farmaceuticas de dispersao solida

Country Status (10)

Country Link
EP (1) EP1227797B1 (pt)
JP (1) JP4815085B2 (pt)
AT (1) ATE286720T1 (pt)
CA (1) CA2390092C (pt)
DE (1) DE60017444T2 (pt)
DK (1) DK1227797T3 (pt)
ES (1) ES2235991T3 (pt)
MX (1) MXPA02004739A (pt)
PT (1) PT1227797E (pt)
WO (1) WO2001034118A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034119A2 (en) 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
MXPA03009971A (es) * 2001-05-03 2004-02-12 Hoffmann La Roche FORMA DE DOSIFICACIoN FARMACEUTICA DE MESILATO DE NELFINAVIR AMORFO.
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US20050048112A1 (en) 2003-08-28 2005-03-03 Jorg Breitenbach Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
BRPI0418330A (pt) 2003-12-31 2007-05-02 Pfizer Prod Inc composições sólidas de drogas de solubilidade baixa e poloxámeros
MY146557A (en) * 2006-12-22 2012-08-30 Yuhan Corp Revaprazan-containing solid dispersion and process for the preparation thereof
JP5593013B2 (ja) * 2007-04-20 2014-09-17 株式会社感光社 固体型殺菌剤及び人体施用組成物
WO2010070611A1 (en) 2008-12-18 2010-06-24 Ranbaxy Laboratories Limited Atazanavir formulations
US9096556B2 (en) 2011-05-27 2015-08-04 Hetero Research Foundation Amorphous ritonavir co-precipitated
EP3569225A1 (en) 2018-05-18 2019-11-20 Pharmaceutical Oriented Services Ltd Solid dispersion containing ritonavir

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110752A (en) * 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor

Also Published As

Publication number Publication date
WO2001034118A3 (en) 2002-01-10
MXPA02004739A (es) 2003-01-28
CA2390092C (en) 2009-07-14
DE60017444D1 (de) 2005-02-17
EP1227797B1 (en) 2005-01-12
ES2235991T3 (es) 2005-07-16
CA2390092A1 (en) 2001-05-17
DK1227797T3 (da) 2005-05-30
JP2003530310A (ja) 2003-10-14
DE60017444T2 (de) 2006-02-09
JP4815085B2 (ja) 2011-11-16
ATE286720T1 (de) 2005-01-15
WO2001034118A2 (en) 2001-05-17
EP1227797A2 (en) 2002-08-07

Similar Documents

Publication Publication Date Title
WO2001034119A3 (en) Inhibitors of crystallization in a solid dispersion
CA2322315A1 (en) Fast disintegrating tablets
DE60121570D1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
PT1227797E (pt) Formulacoes farmaceuticas de dispersao solida
WO2003080023A3 (en) Fast dissolving dosage forms having reduced friability
AR024384A1 (es) UNA FORMA DE DOSIFICACIoN FARMACÉUTICA DE DISOLUCIoN INSTANTÁNEA Y UN MÉTODO PARA PREPARARLA
WO2004100857A3 (en) Highly plastic granules for making fast melting tablets
WO1998009597A3 (en) Cushioning beads and tablet comprising the same capable of forming a suspension
MX358033B (es) Forma de dosificación farmacéutica sólida que comprende al menos un inhibidor de proteasa de hiv.
FI20011851A (fi) Fluoksetiinia tai sen happoadditiosuolaa sisältävä dispergoituva tabletti
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
CA2271196A1 (en) Pharmaceutical compositions of hiv protease inhibitors with improved oral bioavailability
IS5577A (is) Omeprazól örkorn vernduð gegn magasýrum, framleiðsluferli og lyfjasamsetningar
WO2000040205A3 (en) Sustained release formulation with reduced moisture sensitivity
MY127908A (en) Improved pharmaceutical formulations.
HK1040920A1 (en) Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent.
MY119722A (en) Swallow tablet comprising paracetamol.
MY136059A (en) Swallow tablet comprising paracetamol
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
ATE248588T1 (de) Geschmacksmaskierte zubereitungen
PT1263413E (pt) Metodo de preparacao de dispersoes solidas
SE0001916D0 (sv) Novel formulation
MXPA01008348A (es) Microcapsulas para la liberacion prolongada de farmacos.
AR034435A1 (es) Agentes terapeuticos.
DK1349543T3 (da) Fremgangsmåde til fremstilling af tabletter af planteekstrakter